<DOC>
	<DOCNO>NCT02852993</DOCNO>
	<brief_summary>Red blood cell transfusion ( RBC ) main symptomatic treatment severe anemia . RBC transfusion proven efficacy regard mortality morbidity , without side effect . The infectious side effect transfusion largely consider control , non-infectious side effect take center stage . Seeking explanation beneficial deleterious effect RBC transfusion necessary ensure safe optimal use precious resource . The investigator aim study impact donor RBC characteristic patient survival .</brief_summary>
	<brief_title>Survival After Blood Transfusion French Administrative Regions Burgundy Franche-Comté</brief_title>
	<detailed_description />
	<criteria>Aged 18 Erythrocyte Transfusion 2007 2011 Performed University Hospital Besançon Dijon Transfusion blood product prior January 1st , 2007</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Erythrocyte Transfusion</keyword>
	<keyword>Survival</keyword>
</DOC>